Dark

Check out our Dark Pool Levels

ACHL
Achilles Therapeutics plc
stock NASDAQ

Inactive

Mar 20, 2025

1.48USD+0.680%(+0.01)1,204,122

Pre-market

0.00USD-100.000%(-1.47)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 13, 2022

11:46AM EST Achilles Therapeutics Provides Business Update And Outlook For 2022 Benzinga

Dec 21, 2021

08:00AM EST Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that Iraj Ali, Chief Executive Officer, will present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, 2022, at 8:15 a.m. ET. GlobeNewswire Inc

Dec 20, 2021

08:13AM EST Achilles Therapeutics Added To NASDAQ Biotechnology Index As Of Dec. 20, 2021 Benzinga

08:00AM EST Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that the Company has been added to the NASDAQ Biotech Index (Nasdaq: NBI), effective prior to market open today, Monday, December 20, 2021. GlobeNewswire Inc

Dec 9, 2021

09:45PM EST Achilles Therapeutics Presents Positive Data At ESMO I-O Congress 2021 On High-Dose Manufacturing Process For Precision T Cell Therapies Targeting Clonal Neoantigens Benzinga

07:00AM EST -Over 10-fold dose increase at GMP scale with VELOS Process 2 manufacturing- GlobeNewswire Inc

Nov 12, 2021

07:20AM EST Codiak Biosciences, Kymera Therapeutics, Adicet, Celldex, Alector, Achilles, Innate, Celyad, Ruby, Replimune, Nkarta, Ikena, Corvus, Harpoon, Scholar Rock, MiNK, Bolt, Aravive, Oncorus, Editas, Nektar Therapeutics, Compugen, Checkmake Pharma, Iovance, Sensei Highlight Data To Be Presented At Society For Immunotherapy Of Cancer's Meeting Nov. 12-14 Benzinga

07:20AM EST Codiak Biosciences, Kymera Therapeutics, Adicet, Celldex, Achilles, Innate, Celyad, Ruby, Replimune, Nkarta, Ikena, Corvus, Harpoon, Scholar Rock, MiNK, Bolt, Aravive, Oncorus, Editas, Nektar Therapeutics, Compugen, Checkmake Pharma, Iovance, Sensei Highlight Data To Be Presented At Society For Immunotherapy Of Cancer's Meeting Nov. 12-14 Benzinga

07:00AM EST Achilles Therapeutics Presents Data at the Society for GlobeNewswire Inc

Nov 10, 2021

08:22AM EST Secarna Pharmaceuticals, Achilles Therapeutics Sign Research, Option And License Agreement To Develop Optimized T Cell Therapies; Terms Not Disclosed Benzinga

Nov 9, 2021

11:46AM EST Achilles Therapeutics Q3 EPS $(0.34) Benzinga

08:00AM EST - Oral Presentation at European Society for Gene and Cell Therapy (ESGCT) demonstrated ability to generate potent anti-cancer cell therapy candidates in multiple solid tumor types - GlobeNewswire Inc

Oct 22, 2021

07:33AM EDT Achilles Therapeutics Highlights Presentation Of Data At European Society For Gene, Cell Therapy Congress Showing Its Manufacturing Process Can Generate Potent, Personalized Anti-Cancer Cell Therapy Candidates In Multiple Solid Tumor Types Benzinga

07:30AM EDT Achilles Therapeutics Presents Data at the 2021 European Society GlobeNewswire Inc

Oct 12, 2021

08:00AM EDT Achilles Therapeutics to join the Northern Alliance Advanced GlobeNewswire Inc

Oct 1, 2021

08:00AM EDT Achilles Therapeutics to Present at Upcoming Scientific Congresses GlobeNewswire Inc

Sep 27, 2021

06:43AM EDT The following are some of the stocks making big moves in Monday's pre-market trading (as of 6.15 A.M. EDT). RTTNews

Sep 16, 2021

07:48AM EDT The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study Benzinga

Sep 2, 2021

08:30AM EDT Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that management will present at the following investor conferences in September. GlobeNewswire Inc

Aug 25, 2021

08:26AM EDT Achilles Therapeutics Announces Grant Of US And European Patents RTTNews

08:10AM EDT Achilles Therapeutics Reports Grant Of US, European Patents Benzinga

08:00AM EDT Achilles Therapeutics Announces Grant of US and European Patents GlobeNewswire Inc

Aug 13, 2021

07:43AM EDT The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO Benzinga

Aug 11, 2021

10:36AM EDT Mid-Morning Market Update: Markets Mostly Higher; Wendy's Posts Upbeat Earnings Benzinga

Aug 10, 2021

07:17AM EDT Achilles Therapeutics Q2 EPS $(0.45) Benzinga

07:00AM EDT Presentations of translational science data at AACR and ASCO illustrate crucial path to potency assay GlobeNewswire Inc

Jul 28, 2021

07:33AM EDT The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal Benzinga

Jul 27, 2021

11:13AM EDT The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts Benzinga

Jul 16, 2021

07:37AM EDT The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study Benzinga

Jul 15, 2021

08:08AM EDT The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs Benzinga

Jul 14, 2021

07:48AM EDT The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues Benzinga

Jul 9, 2021

07:36AM EDT The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO Benzinga

Jul 8, 2021

07:45AM EDT The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test Benzinga

Jul 7, 2021

07:41AM EDT The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend Benzinga

Jul 1, 2021

08:12AM EDT Achilles Therapeutics Reports Enrollment Of First US Patient In Ongoing Phase 1/2a Study In Advanced Non-Small Cell Lung Cancer Benzinga

08:10AM EDT Achilles Therapeutics Enrolls First US Patient In Phase I/IIa CHIRON Trial In Advanced Non-small Cell Lung Cancer RTTNews

08:07AM EDT The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts Benzinga

08:00AM EDT - Patient enrolled at the Moffitt Cancer Center, FL where Dr. Benjamin Creelan is the Principal Investigator - GlobeNewswire Inc

Jun 30, 2021

07:29AM EDT The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs Benzinga

Jun 29, 2021

08:17AM EDT The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout Benzinga

Jun 25, 2021

07:32AM EDT The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs Benzinga

Jun 16, 2021

08:20AM EDT The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO Benzinga

Jun 15, 2021

08:07AM EDT The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda Benzinga

Jun 4, 2021

09:11AM EDT Achilles Therapeutics Details Phase I/IIa Clinical Trial Design Of CHIRON In Patients With Advanced Non-Small Cell Lung Cancer At 2021 ASCO Meeting Benzinga

09:00AM EDT Achilles Therapeutics Details Phase I/IIa Clinical Trial Design of GlobeNewswire Inc

May 14, 2021

07:59AM EDT The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts Benzinga

May 11, 2021

07:25AM EDT Achilles Therapeutics Q1 EPS $(8.38) Benzinga

07:00AM EDT - Reported first clinical data from the CHIRON and THETIS trials and received recommendation from the Independent Data Safety Monitoring Committee to continue trials as planned - GlobeNewswire Inc

May 6, 2021

08:00AM EDT Achilles Therapeutics Receives Horizon 2020 Grant as Part of GlobeNewswire Inc

May 5, 2021

08:46AM EDT Achilles Therapeutics To Present At BofA Securities 2021 Virtual Healthcare Conference May 13 Benzinga

08:30AM EDT Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that Iraj Ali, Chief Executive Officer, will participate in a fireside chat at the BofA Securities 2021 Virtual Healthcare Conference on Thursday, May 13, 2021, at 9:30 a.m. ET / 2:30 p.m. BST. GlobeNewswire Inc

May 3, 2021

08:00AM EDT Achilles Therapeutics Appoints Julie ONeill to GlobeNewswire Inc

Apr 26, 2021

11:06AM EDT Achilles Therapeutics shares were trading higher after multiple firms initiated coverage on the stock with a bullish rating. Benzinga

10:06AM EDT Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2021 Benzinga

08:59AM EDT JP Morgan Initiates Coverage On Achilles Therapeutics with Underweight Rating, Announces Price Target of $11 Benzinga

08:00AM EDT B of A Securities Initiates Coverage On Achilles Therapeutics with Buy Rating, Announces Price Target of $20 Benzinga

07:52AM EDT Chardan Capital Initiates Coverage On Achilles Therapeutics with Buy Rating, Announces Price Target of $27 Benzinga

06:15AM EDT Piper Sandler Initiates Coverage On Achilles Therapeutics with Overweight Rating, Announces Price Target of $25 Benzinga

06:11AM EDT Oppenheimer Initiates Coverage On Achilles Therapeutics with Outperform Rating, Announces Price Target of $23 Benzinga

Apr 24, 2021

09:24AM EDT The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx Benzinga

Apr 13, 2021

08:16AM EDT The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug Benzinga

Apr 12, 2021

10:19AM EDT Achilles Therapeutics Saturday Morning Demonstrated cNeT Product Characterization, Post-Infusion Tracking In Patient Case Study At American Association For Cancer Research Conference Benzinga

Apr 10, 2021

08:30AM EDT Achilles Therapeutics Demonstrates cNeT Product Characterization GlobeNewswire Inc

Apr 7, 2021

07:58AM EDT The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award Benzinga

Apr 6, 2021

04:01PM EDT Achilles Therapeutics Announces Closing of $175.5 million Initial GlobeNewswire Inc

08:05AM EDT The Daily Biotech Pulse: Illumina Lights Up, Cara Soars On Index Inclusion, Novavax Starts Crossover Vaccine Study, Turning Point Data Readout Benzinga

Mar 31, 2021

11:14AM EDT Achilles Therapeutics Shares Open For Trade At $18; IPO Priced At $18/Share Benzinga

09:21AM EDT Achilles Therapeutics Shares Will Open For Quote At 10:35 a.m. EDT, Expected To Open For Trade After 10:45 a.m. EDT; IPO Priced At $18/Share Benzinga

Mar 30, 2021

07:00PM EDT Achilles Therapeutics Announces Pricing of Initial Public Offering GlobeNewswire Inc

Mar 29, 2021

10:04AM EDT Let's Take a Look At Some Upcoming IPOs This Week Benzinga

Share